Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ruth Harman


Senior Trial Manager - Oncology Clinical Trials Office (OCTO)

I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in May 2019. Prior to this I was a Research Administrator for the HOME Study in the University’s Department of Psychiatry.

I have worked on a number of OCTO trials, including:

ARCADIAN – a phase I trial to assess the safety of combining the drug atovaquone with concurrent chemoradiotherapy in locally advanced Non-Small Cell Lung Cancer.

ATOM – A pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma.

CHARIOT – A phase I dose escalation safety trial combining the ATR inhibitor M6620 with chemoradiotherapy in oesophageal cancer and other solid cancers using time to event continual reassessment method.

CYTOFLOC – A trial to investigate the safety and tolerability of a non-endoscopic device called a CytospongeTM for post-chemoradiotherapy surveillance of oesophageal cancer patients . 

Information on other OCTO trials can be found here.